Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to dabrafenib or trametinib.

Amir Noeparast, Gil Verschelden, Ijeoma Umelo, Sylvia De Brakeleer, Lore Decoster, Erik Teugels, Jacques De Greve

Onderzoeksoutput: Meeting abstract (Journal)

Originele taal-2	English
Pagina's (van-tot)	11091
Tijdschrift	Journal of Clinical Oncology
Volume	33
Nummer van het tijdschrift	15
Status	Published - 20 mei 2015
Evenement	Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duur: 29 mei 2015 → 2 jun 2015

Citeer dit

@article{a9cd19fb6ac24f868c03a5504c15240c,

title = "Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to dabrafenib or trametinib.",

author = "Amir Noeparast and Gil Verschelden and Ijeoma Umelo and {De Brakeleer}, Sylvia and Lore Decoster and Erik Teugels and {De Greve}, Jacques",

year = "2015",

month = may,

day = "20",

language = "English",

volume = "33",

pages = "11091",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "Annual Meeting of the American Society of Clinical Oncology (ASCO) ; Conference date: 29-05-2015 Through 02-06-2015",

}

TY - JOUR

T1 - Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to dabrafenib or trametinib.

AU - Noeparast, Amir

AU - Verschelden, Gil

AU - Umelo, Ijeoma

AU - De Brakeleer, Sylvia

AU - Decoster, Lore

AU - Teugels, Erik

AU - De Greve, Jacques

PY - 2015/5/20

Y1 - 2015/5/20

M3 - Meeting abstract (Journal)

VL - 33

SP - 11091

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15

T2 - Annual Meeting of the American Society of Clinical Oncology (ASCO)

Y2 - 29 May 2015 through 2 June 2015

ER -